Table: Taiko Pharmaceutical - 9-MTH group results

Taiko Pharmaceutical

09/11/2021 06:15

Nov 9 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2021        Dec 31, 2020      Dec 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             8.36                                  12.50     
  Operating       loss 1.58                             loss 2.00   
  Recurring       loss 2.39                             loss 3.40   
  Net             loss 1.95                             loss 2.80   
  EPS          loss 44.79 yen                        loss 64.24 yen 
  Ann Div                             25.00 yen            NIL      
  -Q2 div            NIL              7.00 yen                      
  -Q4 div                             18.00 yen            NIL      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T